InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,930.85
(
1.09%
)
US TECH 100
20,836.00
(
1.31%
)
Dow Jones
42,840.26
(
1.18%
)
Brent Oil
72.72
(
0.00%
)
Bitcoin
95,177.05
(
-2.09%
)
Post# of 41063
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

bayarea

Send PM Follow Ignore
Followers 15
Posts 2439
Boards Moderated 0
Alias Born 04/06/2009

bayarea

Re: None

Monday, 05/02/2011 10:50:16 AM

Monday, May 02, 2011 10:50:16 AM

Post# of 41063
Spectrum Pharmaceuticals Inc. (SPPI, $9.72, +$0.72, +8.00%) said it won U.S. regulatory approval to promote its Fusilev drug for colorectal cancer treatment, a new indication that will allow the injection to be more widely marketed.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up